An organ-on-a-chip is a microfluidic cell culture device, which is developed by microchip manufacturing methods which contain continuously perfused chambers inhabited by living cells arranged to simulate tissue and organ-level physiology. The organs-on-chips market is expected to reach $85.19 Million by 2024 from $9.6 Million in 2017, at a CAGR of 36.6%. Rising number of partnerships and collaborations between companies and Increasing focus on developing alternatives for animal testing models are the drivers that boost the market growth. Growing focus on drug discovery activities and the development of multiple organs on a chip model are the major opportunities for the market. On the flip side, the complexity of organs on chips models and issues related to the incorporation of organs on chips technologies are the restraints that hamper the market growth.
Research Study Objectives:
- Define, estimate, and forecast the Organs on Chips market statistics by offering, type, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Organs on Chips market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints &Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Organs on Chips Market Analysis report.
- Analysis and conclusions on the future Organs on Chips market outlook.
Top-down and bottom-up approaches are used to validate the Organs on Chips Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary
sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Organs on Chips Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Organs on Chips market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Organs on Chips market segmentation is as follows:
By Offering
By Type
- Kidney
- Lung
- Heart
- Other Organs
By Application
- Drug Discovery
- Physiological Model Development
- Toxicology Research
By End User
- Cosmetics Industry
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
Geographical Analysis:
Organs on Chips Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and
many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Organs on Chips Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Organs on Chips Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Organs on Chips market players, such as
- Nortis Bio
- Ascendance Biotechnology, Inc
- Emulate, Inc.
- Kirkstall
- Hurel Corporation
- Along with these companies, many other companies are considered in the report while analysing the Global Organs on Chips competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
